Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents
- 1 April 2000
- journal article
- Published by Elsevier in Drug Resistance Updates
- Vol. 3 (2) , 83-88
- https://doi.org/10.1054/drup.2000.0129
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cell proliferation and apoptosisCurrent Opinion in Cell Biology, 1999
- An Overview of Plasmodium Protein KinasesParasitology Today, 1999
- Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and cip and INK4 inhibitorsJournal of Molecular Biology, 1999
- CYCLIN-DEPENDENT KINASES: Engines, Clocks, and MicroprocessorsAnnual Review of Cell and Developmental Biology, 1997
- Biochemical and Cellular Effects of Roscovitine, a Potent and Selective Inhibitor of the Cyclin‐Dependent Kinases cdc2, cdk2 and cdk5European Journal of Biochemistry, 1997
- Inhibition of Cyclin‐Dependent Kinases by Purine AnaloguesEuropean Journal of Biochemistry, 1997
- Chemical inhibitors of cyclin-dependent kinasesTrends in Cell Biology, 1996
- Inhibition of Cyclin‐Dependent Kinases by Purine AnaloguesEuropean Journal of Biochemistry, 1994
- Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2Nature, 1987
- Gene required in G1 for commitment to cell cycle and in G2 for control of mitosis in fission yeastNature, 1981